Metsera (MTSR) News Today $51.90 +0.20 (+0.39%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MTSR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Metsera, Inc. (MTSR) was downgraded to a Hold Rating at Wells FargoOctober 2 at 4:31 PM | theglobeandmail.comMetsera (NASDAQ:MTSR) Rating Lowered to "Equal Weight" at Wells Fargo & CompanyOctober 2 at 2:25 AM | americanbankingnews.comMetsera Announces Positive Phase 2b Trial ResultsOctober 2 at 2:39 AM | msn.comMetsera (NASDAQ:MTSR) Upgraded by Wall Street Zen to "Hold" RatingOctober 1 at 3:19 AM | americanbankingnews.comMetsera (NASDAQ:MTSR) Raised to "Hold" at Wall Street ZenOctober 1 at 3:17 AM | marketbeat.comHealthy Returns: Pfizer's new obesity bet, Metsera, releases encouraging data on lead drugSeptember 30 at 3:39 PM | cnbc.comMetsera (NASDAQ:MTSR) Cut to Equal Weight at Wells Fargo & CompanySeptember 30 at 8:50 AM | marketbeat.comMetsera downgraded to Equal Weight from Overweight at Wells FargoSeptember 29, 2025 | msn.comMetsera's obesity drug shows promising weight loss in mid-stage trialsSeptember 29, 2025 | reuters.comMetsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3September 29, 2025 | globenewswire.comMetsera (MTSR): Rethinking Valuation After a Quiet 49% RallySeptember 27, 2025 | finance.yahoo.comMetsera (NASDAQ:MTSR) Cut to "Hold" at Leerink PartnrsSeptember 27, 2025 | americanbankingnews.comMetsera Inc. (NASDAQ:MTSR) Receives $63.50 Average PT from AnalystsSeptember 27, 2025 | americanbankingnews.comPfizer is Locking in New Growth Through a New Acquisition (MTSR)Pfizer is undergoing a new acquisition, exposing it to the weight loss market and additional revenue growth potential, which isn't priced in yet.September 26, 2025 | marketbeat.comGoldman Sachs Group Inc. Buys Shares of 20,856 Metsera Inc. $MTSRSeptember 26, 2025 | marketbeat.comLeerink Partners Downgrades Metsera (MTSR)September 26, 2025 | msn.comMetsera (NASDAQ:MTSR) Receives "Market Perform" Rating from Leerink PartnersSeptember 26, 2025 | americanbankingnews.comMetsera downgraded to Market Perform from Outperform at LeerinkSeptember 25, 2025 | finance.yahoo.comMetsera (NASDAQ:MTSR) Lowered to Hold Rating by Leerink PartnrsSeptember 25, 2025 | marketbeat.comMetsera (NASDAQ:MTSR) Earns Market Perform Rating from Leerink PartnersSeptember 24, 2025 | marketbeat.comRhumbline Advisers Invests $520,000 in Metsera Inc. $MTSRSeptember 24, 2025 | marketbeat.comMetsera Inc. (NASDAQ:MTSR) Receives Consensus Rating of "Buy" from AnalystsSeptember 24, 2025 | marketbeat.comMorning Movers: Metsera surges, Pfizer gains after acquisition pactSeptember 23, 2025 | msn.comMetsera (MTSR) Soars to All-Time High on $7.3-Billion Merger With PfizerSeptember 23, 2025 | msn.comMETSERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Metsera, Inc. - MTSRSeptember 23, 2025 | businesswire.comSHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Metsera, Inc. (NASDAQ: MTSR)September 23, 2025 | prnewswire.comMetsera (NASDAQ:MTSR) Sees Large Volume Increase - What's Next?September 23, 2025 | marketbeat.comWhat's Pfizer Getting in Its $7.3 Billion Metsera Buyout?September 23, 2025 | fool.comMetsera (NASDAQ:MTSR) Downgraded by Wall Street Zen to "Sell"September 23, 2025 | marketbeat.comExchange Traded Concepts LLC Acquires New Position in Metsera Inc. $MTSRSeptember 23, 2025 | marketbeat.comPfizer Buys Weight-Loss Drug Developer Metsera For $7.3 BillionSeptember 22, 2025 | baystreet.caPfizer doubles down on weight-loss treatments with up to $7.3 billion Metsera buyoutSeptember 22, 2025 | msn.comMetsera Buyout Confirms Obesity as Strategic Pivot for Pfizer’s Growth StorySeptember 22, 2025 | in.investing.comPfizer Jumps Into Weight-Loss Drug Segment With $7.3 Billion Metsera DealSeptember 22, 2025 | msn.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ODP and MTSR on Behalf of ShareholdersSeptember 22, 2025 | prnewswire.comMetsera (NASDAQ:MTSR) Sets New 52-Week High - Should You Buy?September 22, 2025 | marketbeat.comShareholder Alert: The Ademi Firm investigates whether Metsera Inc. is obtaining a Fair Price for its Public ShareholdersSeptember 22, 2025 | prnewswire.comPfizer acquires Metsera in $7.3B deal to boost obesity drug pipelineSeptember 22, 2025 | proactiveinvestors.comPfizer close to $7.3 bln takeover of weight loss drugmaker Metsera- FTSeptember 22, 2025 | ca.investing.comM&A News: Metsera Stock (MTSR) Rallies over 50% as Pfizer Nears $7.3B TakeoverSeptember 22, 2025 | msn.comPfizer boosts obesity drug prospects with $7.3 billion deal to buy MetseraSeptember 22, 2025 | cnbc.comMTSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Metsera, Inc. Is Fair to ShareholdersSeptember 22, 2025 | businesswire.comPfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 BillionSeptember 22, 2025 | wsj.comPfizer to buy weight-loss drug developer Metsera for up to $4.9 billionSeptember 22, 2025 | reuters.comPfizer to Acquire Metsera and its Next-Generation Obesity PortfolioSeptember 22, 2025 | businesswire.comPfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reportsSeptember 21, 2025 | reuters.comMetsera Reaches 80-Plus Relative Strength Rating BenchmarkSeptember 19, 2025 | msn.comMetsera (NASDAQ:MTSR) Shares Up 4.9% - Still a Buy?September 18, 2025 | marketbeat.comMetsera (NASDAQ:MTSR) Trading Down 4.3% - Here's WhySeptember 16, 2025 | marketbeat.comMetsera (NASDAQ:MTSR) Raised to Hold at Wall Street ZenSeptember 16, 2025 | marketbeat.com Get Metsera News Delivered to You Automatically Sign up to receive the latest news and ratings for MTSR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MTSR Media Mentions By Week MTSR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MTSR News Sentiment▼0.260.52▲Average Medical News Sentiment MTSR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MTSR Articles This Week▼156▲MTSR Articles Average Week Get the Latest News and Ratings for MTSR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Metsera and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies TEVA News GMAB News SMMT News ASND News RDY News VTRS News ROIV News QGEN News MRNA News ELAN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MTSR) was last updated on 10/3/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metsera Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Metsera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MTSR Stock Alerts